1127347

Keila Hoover, M.D. — FEI 3016483191

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 12, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)